Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy-Reference-Cited by-同舟云学术

Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy

Published:2011-10-21 Issue:1 Volume:107 Page:197-205
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Pope Whitney B.,Prins Robert M.,Albert Thomas M.,Nagarajan Rajakumar,Yen Katharine E.,Bittinger Mark A.,Salamon Noriko,Chou Arthur P.,Yong William H.,Soto Horacio,Wilson Neil,Driggers Edward,Jang Hyun G.,Su Shinsan M.,Schenkein David P.,Lai Albert,Cloughesy Timothy F.,Kornblum Harley I.,Wu Hong,Fantin Valeria R.,Liau Linda M.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-011-0737-8.pdf

Reference32 articles.

1. Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A (2008) Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol 116(6):597–602

2. Bleeker FE, Lamba S, Leenstra S, Troost D, Hulsebos T, Vandertop WP et al (2009) IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. Hum Mutat 30(1):7–11

3. De Carli E, Wang X, Puget S (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360(21):2248 author reply 9

4. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321(5897):1807–1812

5. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W et al (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360(8):765–773

Cited by 269 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IDH inhibition in gliomas: from preclinical models to clinical trials;Nature Reviews Neurology;2024-05-17

2. Diagnostic and Theranostic Opportunities in Neuro-Oncology;Advances in Oncology;2024-05

3. 2-Hydroxyglutarate as an MR spectroscopic predictor of an IDH mutation in gliomas;RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren;2024-04-22

4. Prediction of metabolites associated with somatic mutations in cancers by using genome-scale metabolic models and mutation data;Genome Biology;2024-03-11

5. The diagnostic efficiency of integration of 2HG MRS and IVIM versus individual parameters for predicting IDH mutation status in gliomas in clinical scenarios: A retrospective study;Journal of Neuro-Oncology;2024-02-29